chronic lymphocytic leukemia

(redirected from Chronic lymphocytic leukaemia)
Also found in: Thesaurus, Medical.
Related to Chronic lymphocytic leukaemia: chronic lymphocytic leukemia
ThesaurusAntonymsRelated WordsSynonymsLegend:
Noun1.chronic lymphocytic leukemia - chronic leukemia characterized by lymphoblast-like cells; more common in older men
chronic leukemia - slowly progressing leukemia
Based on WordNet 3.0, Farlex clipart collection. © 2003-2012 Princeton University, Farlex Inc.
References in periodicals archive ?
M2 EQUITYBITES-August 15, 2019-AstraZeneca gains FDA Breakthrough Therapy Designation for Calquence for chronic lymphocytic leukaemia
M2 PHARMA-August 15, 2019-AstraZeneca gains FDA Breakthrough Therapy Designation for Calquence for chronic lymphocytic leukaemia
M2 PRESSWIRE-August 14, 2019-: Calquence granted US Breakthrough Therapy Designation for chronic lymphocytic leukaemia
The team created a compound using feverfew, a common flowering garden plant, to kill chronic lymphocytic leukaemia (CLL) cells.
Jose Baselga, Executive Vice President, Oncology R&D said: "These data add to the growing body of evidence to support the profile of Calquence as a selective BTK inhibitor that offers a chemotherapy-free treatment option with a favourable safety profile in chronic lymphocytic leukaemia, a life-threatening disease.
(Alliance News) - AstraZeneca PLC on Saturday said its drug Calquence significantly prolonged the time patients lived without disease progression in chronic lymphocytic leukaemia.
AstraZeneca Plc (LON:AZN), a global, science-led biopharmaceutical company, announced on Tuesday positive results from the phase III ASCEND trial of Calquence(acalabrutinib) in previously-treated patients with chronic lymphocytic leukaemia (CLL).
Chronic lymphocytic leukaemia. Nat Rev Dis Primers 2017; 3: 16096.
Now it's just the coffee and chat as I'm having chemotherapy for CLL (chronic lymphocytic leukaemia).
Roche announced data from the final analysis of the CLL11 study evaluating Gazyva/Gazyvaro-based treatment in previously untreated chronic lymphocytic leukaemia, or CLL, which will be presented during the Presidential Symposium at the 23rd European Hematology Association Annual Congress, 14-17 June, in Stockholm.
Weissmann et al., "Accumulation of adverse prognostic markers worsens prognosis in chronic lymphocytic leukaemia," British Journal of Haematology, vol.

Full browser ?